Literature DB >> 15681859

Expression of caveolin-1 and caveolin-2 in the human pituitary: an immunohistochemical study.

Fabio Rotondo1, Eva Horvath, Kalman Kovacs, David C Bell, Ricardo V Lloyd, Bernd W Scheithauer.   

Abstract

Caveolins are coat proteins of caveolae, the plasmalemmal transport vesicles. To our knowledge their presence in the human pituitary and various types of hypophysial adenomas has not been investigated. In the present work, expression of caveolin-1 and caveolin-2 was studied by immunohistochemistry using the streptavidin-biotin-peroxidase complex method. The material included 7 autopsy obtained, 5 surgically removed non-tumorous pituitaries, and 97 hypophysial adenomas classified on the basis of histologic immunohistochemical and ultrastructural features. No immunoreactivity was seen for caveolin-1 and caveolin-2 in non-tumorous adenohypophysial and neurohypophysial cells and in the tumor cells, indicating that caveolins are not involved in the initiation and progression of pituitary adenomas. The expression of caveolin-1 and caveolin-2 in the endothelial cells did not depend on age, gender, endocrine status of the patients, morphologic features, and type of pituitary tumors. Scattered endothelial cells were immunopositive for both caveolins showing similar cytoplasmic localization. Evidence that the two caveolins were indeed localized to the same endothelial cell was demonstrated on consecutive sections using Factor-8 and CD-34, two reliable endothelial cell markers. Not every endothelial cell was immunoreactive for the two caveolins, suggesting that the functional status of endothelial cells is not the same within the adenomas, not even in the same capillary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15681859     DOI: 10.1385/ep:15:4:345

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  28 in total

Review 1.  Caveolae: an alternative membrane transport compartment.

Authors:  M Gumbleton; A G Abulrob; L Campbell
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

Review 2.  Attenuation of EGF signaling in senescent cells by caveolin.

Authors:  W Y Park; K A Cho; J S Park; D I Kim; S C Park
Journal:  Ann N Y Acad Sci       Date:  2001-04       Impact factor: 5.691

Review 3.  Upregulation of caveolin in multidrug resistant cancer cells: functional implications.

Authors:  Y Lavie; G Fiucci; M Liscovitch
Journal:  Adv Drug Deliv Rev       Date:  2001-07-28       Impact factor: 15.470

Review 4.  Cell biology of caveolae and caveolin.

Authors:  J Couet; M M Belanger; E Roussel; M C Drolet
Journal:  Adv Drug Deliv Rev       Date:  2001-07-28       Impact factor: 15.470

5.  Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.

Authors:  K Kovacs; L Stefaneanu; E Horvath; R V Lloyd; I Lancranjan; M Buchfelder; R Fahlbusch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 7.  Caveolae and the caveolins in human disease.

Authors:  L Campbell; M Gumbleton; K Ritchie
Journal:  Adv Drug Deliv Rev       Date:  2001-07-28       Impact factor: 15.470

8.  Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.

Authors:  J Liu; B Razani; S Tang; B I Terman; J A Ware; M P Lisanti
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

9.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells.

Authors:  S W Lee; C L Reimer; P Oh; D B Campbell; J E Schnitzer
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

10.  Decreased expression of caveolin-1 and altered regulation of mitogen-activated protein kinase in cultured bovine parathyroid cells and human parathyroid adenomas.

Authors:  Olga Kifor; Imre Kifor; Francis D Moore; Robert R Butters; Thomas Cantor; Ping Gao; Edward M Brown
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.